在受损宿主中管理系统性真菌菌.

Same author

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Leukemia & lymphoma·2016

Same author

Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014

Same author

Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century?

Clinical oncology (Royal College of Radiologists (Great Britain))·2006

Same author

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Lancet (London, England)·2005

Same author

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Same author

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.

European journal of cancer (Oxford, England : 1990)·2004

相关实验视频

在受损宿主中管理系统性真菌菌.

相关概念视频

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.

Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century?

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.

相关实验视频

在受损宿主中管理系统性真菌菌.

相关概念视频

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.

Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century?

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.

相关实验视频

在受损宿主中管理系统性真菌菌.

相关概念视频

相关文章

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.

Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century?

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.

相关实验视频

在受损宿主中管理系统性真菌菌.

相关概念视频

相关文章

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.

Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century?

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.